Tag: Deviation

Investigating a Repeated OOS Trend Overlooked During FDA Inspection: A CAPA Case Study In the highly regulated pharmaceutical industry, maintaining strict adherence to Good Manufacturing Practices (GMP) is essential for…

Analysis of a Data Integrity Breach Due to Unauthorized Method Modification In the rigorous world of pharmaceutical manufacturing, any deviation from standard operating procedures (SOPs) can have significant consequences. This…

Investigation of Unauthorized Method Modifications: A Case Study of Inspection Citations Pharmaceutical organizations face stringent regulatory pressure to maintain compliance and uphold data integrity throughout their processes. In this case…

Investigation of a System Suitability Failure Ignored During Routine Testing in a QC Laboratory In the highly regulated pharmaceutical manufacturing environment, the integrity of data stemming from quality control testing…

Addressing Analyst Training Gaps During Method Transfer: A Case Study In a recent Quality Control (QC) laboratory scenario, a series of deviations were identified during routine testing of a new…

Case Analysis of a Sample Preparation Error: Insights from a Data Review CAPA Failure In the highly regulated pharmaceutical manufacturing landscape, deviations in quality control (QC) processes can lead to…

Understanding and Addressing Analyst Training Gaps in Routine Testing: A Case Study of Data Integrity Breach In the realm of pharmaceutical manufacturing, maintaining data integrity is paramount. This case study…

Case Study: Overlooking System Suitability Failures During Routine Testing In the pharmaceutical manufacturing landscape, the integrity and reliability of laboratory testing processes are crucial for compliance with Good Manufacturing Practice…

Case Study on Backdated Test Records During FDA Inspections: Navigating Regulatory Risks In the realm of pharmaceutical manufacturing, maintaining compliance with regulatory standards is paramount. An incident involving backdated test…

Case Study: Addressing OOS Invalidations Without Justification During Routine Testing In the rigorous environment of pharmaceutical manufacturing and quality control (QC), deviations from expected results can trigger complex investigations. A…

Analysis of Unauthorized Method Modification During Method Transfer: A Case Study In an increasingly regulated pharmaceutical landscape, maintaining data integrity is paramount. A recent incident at a pharmaceutical manufacturing facility…

Addressing Unapproved Chromatographic Integration Issues in Method Transfer In the pharmaceutical industry, method transfer is a critical phase where analytical methods are verified for consistency and reliability across different laboratory…